Vaccine Business Expansion: Pharma Industry Seeks Capital Support from Danantara
The President Director of Bio Farma, Shadiq Akasya, has confirmed that Bio Farma is prioritising efforts to strengthen national vaccine resilience before expanding vaccine exports to assist other nations.
Amidst efforts to increase domestic vaccine production capacity and build a more self-sufficient pharmaceutical ecosystem, Bio Farma continues to face challenges regarding the dependency on imported raw materials. To reduce this reliance, Bio Farma, as a pharmaceutical holding company, has undertaken several initiatives to develop domestic raw materials. This includes efforts by its subsidiary, PT Kimia Farma Sungwun Pharmacopia, which is now capable of producing 19 active molecules to meet domestic pharmaceutical needs.
In its pursuit of increased productivity, Bio Farma is focusing on two fronts: manufacturing output and human resource productivity. Consequently, Bio Farma is driving revenue by focusing on meeting the demand for vaccines in both domestic and international markets, in accordance with WHO guidelines.
Bio Farma also ensures the implementation of Good Corporate Governance (GCG) by maintaining professional business management while carefully managing business risks. Furthermore, Bio Farma is looking for full support from Danantara, as the parent entity of State-Owned Enterprises (SOEs), particularly regarding funding.
By 2026, Bio Farma aims to achieve its Work Plan and Budget (RKAB) targets by focusing on the development of new vaccines, including vaccines for HPV, typhoid, malaria, and Dengue Hemorrhagic Fever (DHF), to meet both domestic and export demands. Meanwhile, Bio Farma remains committed to ensuring that essential vaccines, such as Polio, Tetanus, and Diphtheria vaccines, are produced with more effective packaging that meets international standards.
More from 12 September 2026 โ
Source: jawawa.id (https://jawawa.id/newsitem/vaccine-business-expansion-pharma-industry-seeks-capital-support-from-danantara-1789195961)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/news/20260907122546-8-765750/viodeo-ekspansi-bisnis-vaksin-farma-harap-bantuan-modal-danantara), translated from Indonesian